Gainers
- Strata Skin Sciences SSKN stock increased by 11.27% to $1.48 during Monday's after-market session. Today's trading volume for this security ended up closing at 112.0K shares, which is 195.09 percent of its average volume over the last 100 days. The company's market cap stands at $50.0 million. As per the news, the Q2 earnings report came out today.
- Forte Biosciences FBRX shares increased by 9.28% to $26.01. The company's market cap stands at $351.4 million.
- Qualigen Therapeutics QLGN stock moved upwards by 8.98% to $1.82. The market value of their outstanding shares is at $52.4 million.
- NanoVibronix NAOV stock moved upwards by 6.52% to $3.59. NanoVibronix's trading volume hit 3.1 million shares by close, accounting for 20.56% of its average volume over the last 100 days. The company's market cap stands at $86.5 million. As per the news, the Q2 earnings report came out today.
- Sesen Bio SESN stock rose 4.91% to $1.28. Trading volume for this security closed at 1.5 million, accounting for 17.06% of its average full-day volume over the last 100 days. The company's market cap stands at $250.8 million.
- Nymox Pharmaceutical NYMX stock rose 4.22% to $1.85. The market value of their outstanding shares is at $152.4 million. As per the news, the Q2 earnings report came out yesterday.
Losers
- Sema4 Holdings SMFR shares decreased by 18.67% to $9.24 during Monday's after-market session. The company's market cap stands at $2.2 billion. The company's, Q2 earnings came out today.
- OncoSec Medical ONCS shares declined by 8.68% to $2.0. The company's market cap stands at $78.3 million.
- HealthEquity HQY stock fell 5.67% to $61.3. This security traded at a volume of 73.5K shares come close, making up 17.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $5.1 billion.
- Rockwell Medical RMTI stock fell 3.32% to $0.59. The company's market cap stands at $55.2 million. As per the press release, Q2 earnings came out today.
- Streamline Health Solns STRM stock declined by 2.76% to $1.41. The company's market cap stands at $59.7 million.
- Cyclerion Therapeutics CYCN stock declined by 2.65% to $2.95. The company's market cap stands at $127.6 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in